Luis Malave - 25 Mar 2025 Form 4 Insider Report for Glucotrack, Inc. (GCTK)

Reporting relationship: Director
Issuer ticker: GCTK
Reported as of: 25 Mar 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Oct 2025, 21:06:05 UTC
Prior SEC filing: 31 Mar 2025
Source filing: View source filing
Reporting owner signature: /s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact

Key filing fact

Luis Malave filed Form 4 for Glucotrack, Inc. (GCTK) on 07 Oct 2025.

Key facts

This page summarizes Luis Malave's Form 4 filing for Glucotrack, Inc. (GCTK).
4 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 07 Oct 2025, 21:06.

Change

Previous filing in this sequence was filed on 31 Mar 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001395781 Primary reporting owner

Malave Luis

Relationship: Director
Address: C/O GLUCOTRACK, INC., 301 RTE. 17 NORTH, SUITE 800, RUTHERFORD
Signature: /s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact
Signature date: 07 Oct 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GCTK transaction

Common Stock, par value $0.001 per share

Award

Transaction value: $0
Shares: +35
Change %: +1.5%
Price: $0.000000
Shares after: 2,395
Date: 25 Mar 2025
Ownership: Direct

GCTK transaction

Common Stock, par value $0.001 per share

Award

Transaction value: $0
Shares: +1,200
Change %: +50%
Price: $0.000000
Shares after: 3,595
Date: 11 Jul 2025
Ownership: Direct

GCTK transaction

Common Stock, par value $0.001 per share

Award

Transaction value: $0
Shares: +463
Change %: +13%
Price: $0.000000
Shares after: 4,058
Date: 03 Oct 2025
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GCTK transaction Derivative

Stock option (right to buy)

Award

Transaction value: $0
Shares: +4,055
Change %
Price: $0.000000
Shares after: 4,055
Date: 03 Oct 2025
Ownership: Direct
Underlying class: Common Stock, par value $0.001 per share
Underlying amount: 4,055
Exercise price: $7.40
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Each option grant has a vesting commencement date of July 1 of the applicable calendar year and vests in 12 equal monthly installments over the 12-month period ending June 30 of the following year, subject to the reporting person's continued service to the Issuer through each vesting date.

SEC remarks

On May 17, 2024, a 1-for-5 reverse stock split of the Issuer's common stock, par value $0.001 per share (the "Common Stock") was implemented (the "2024 Reverse Split"). On February 25, 2025, a 1-for-20 reverse stock split of the Common Stock was implemented (the "February 2025 Reverse Split"), and on June 13, 2025, a 1-for-60 reverse stock split of the Common Stock was implemented (the "June 2025 Reverse Stock Split", and together with the 2024 Reverse Split and the February 2025 Reverse Stock Split, the "Reverse Stock Splits"). All figures presented in this Form 4 reflect the Reverse Stock Splits.